当前位置: X-MOL首页全球导师 国内导师 › 成红

个人简介

学习经历 2008.09-2012.06 中南大学,应用化学,学士 2012.09-2017.06 武汉大学,高分子化学与物理,博士 工作经历 2017.07-至今 南方医科大学,生物医学工程学院,副教授

研究领域

癌症由于其难以治愈、易转移复发、死亡率高等特点,已经成为威胁人类生命健康的主要疾病之一。但传统肿瘤治疗方式在实际应用过程中面临着诸多问题,如何将药物安全有效地递送至病灶部位,在提高药效的同时降低其对正常组织的毒副作用,一直是该领域研究人员致力于解决的关键问题之一。基于此,我们长期关注生物医用材料应用于肿瘤诊断和治疗的相关研究及动态,通过结合材料科学、生命科学、医学等学科,开发了一系列适应于肿瘤微环境的多功能药物载体,实现药物的可控释放,用于肿瘤的靶向治疗

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Hong Cheng, Jingyi Zhu, Shiying Li, Jingyue Zeng, Qi Lei, Kewei Chen, Chi Zhang, Xianzheng Zhang*, An O2 self-sufficient biomimetic nanoplatform for highly specific and efficient photodynamic therapy, Advanced Functional Materials, 2016, 26, 7847-7860. (SCI, IF: 15.621) Hong Cheng #, Guiling Fan#, Jinghao Fan, Ping Yuan, Fuan Deng, Xiaozhong Qiu, Xiyong Yu, Shiying Li*, Epigenetics-inspired photosensitizer modification for plasma membrane-targeted photodynamic tumor therapy. Biomaterials, 2019, 224, 119497. (SCI, IF: 10.273) Hong Cheng#, Jinghao Fan#, Linping Zhao, Guiling Fan, Rongrong Zheng, Xiaozhong Qiu, Xiyong Yu*, Shiying Li*, Xianzheng Zhang, Chimeric peptide engineered exosomes for dual-stage light guided plasma membrane and nucleus targeted photodynamic therapy, Biomaterials, 2019, 211, 14-24. (SCI, IF: 10.273) Hong Cheng*, Xueyan Jiang, Rongrong Zheng, Shengjia Zuo, Linping Zhao, Guiling Fan, Boru Xie, Xiyong Yu, Shiying Li*, Xianzheng Zhang, A biomimetic cascade nanoreactor for tumor targeted starvation therapy amplified chemotherapy, Biomaterials, 2019, 195, 75-85. (SCI, IF: 10.273) Hong Cheng#, Rongrong Zheng#, Guiling Fan, Jinghao Fan, Linping Zhao, Xueyan Jiang, Bin Yang, Xiyong Yu*, Shiying Li*, Xianzheng Zhang, Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy, Biomaterials, 2019, 188, 1-11. (SCI, IF: 10.273) Hong Cheng#, Ping Yuan#, Guiling Fan, Linping Zhao, Rongrong Zheng, Bin Yang, Xiaozhong Qiu, Xiyong Yu, Shiying Li*, Xianzheng Zhang, Chimeric peptide nanorods for plasma membrane and nuclear targeted photosensitizer delivery and enhanced photodynamic therapy, Applied Materials Today, 2019, 16, 120-131. (SCI, IF: 8.013) Hong Cheng#, Guiling Fan#, Jinghao Fan, Linping Zhao, Rongrong Zheng, Xiyong yu, Shiying Li*, A ratiometric theranostic nanoprobe for pH imaging-guided photodynamic therapy, Nanoscale, 2019, 11, 9008-9014. (SCI, IF: 6.97) Shiying Li#, Xueyan Jiang#, Rongrong Zheng, Shengjia Zuo, Linping Zhao, Guiling Fan, Jinghao Fan, Yonghua Liao, Xiyong Yu*, Hong Cheng*, An azobenzene-based heteromeric prodrug for hypoxia-activated chemotherapy by regulating subcellular localization, Chemical Communications, 2018, 54, 7983-7986. (SCI, IF: 6.164) Hong Cheng, Jingyi Zhu, Xiaoding Xu, Wenxiu Qiu, Qi Lei, Kai Han, Yinjia Cheng, Xianzheng Zhang. Activable cell-penetrating peptide (ACPP) conjugated prodrug for tumor targeted drug delivery. ACS Applied Materials & Interfaces, 2015, 7, 16061-16069. (SCI, IF: 8.456) Hong Cheng, Shiying Li, Haoran Zheng, Chuxin Li, Boru Xie, Kewei Chen, Bin Li, Xianzheng Zhang. Multi-forster resonance energy transfer-based fluorescent probe for spatiotemporal matrix metalloproteinase-2 and caspase-3 imaging. Analytical Chemistry, 2017, 89, 4349-4354. (SCI, IF: 6.35) Hong Cheng, Yinjia Cheng, Sushant Bhasin, Jingyi Zhu, Xiaoding Xu, Renxi Zhuo, Xianzheng Zhang. Complementary hydrogen bonding interaction triggered co-assembly of amphiphilic peptide and anti-tumor Drug, Chemical Communications, 2015, 51, 6936-6939. (SCI, IF: 6.164) Shiying Li#, Hong Cheng#, Wenxiu Qiu, Lu Zhang, Shuangshuang Wan, Jingyue Zeng, Xianzheng Zhang. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Biomaterials, 2017, 142, 149-161. (SCI, IF: 10.273) Shiying Li#, Hong Cheng#, Boru Xie, Wenxiu Qiu, Lilin Song, Xianzheng Zhang. A ratiometric theranostic beacon for tumor targeting therapy and self-therapeutic monitoring. Biomaterials, 2016, 104, 297-309. (SCI, IF: 10.273) Shiying Li#, Hong Cheng#, Wenxiu Qiu, Lihan Liu, Si Chen, Ying Hu, Boru Xie, Bin Li, Xianzheng Zhang. Protease-activable cell-penetrating peptide-protoporphyrin conjugate for targeted photodynamic therapy in vivo. ACS Applied Materials & Interfaces, 2015, 7, 28319-28329. (SCI, IF: 8.456)

推荐链接
down
wechat
bug